Classification of anxiety disorders: Dimensional assessments, intermediate phenotypes, and psychobiological bases Dan J. Stein Invited Commentary 16 October 2008 Pages: 287 - 289
Pharmacotherapy of anxious depression Dan J. Stein Clinical Trials Report 16 October 2008 Pages: 295 - 296
Social support and resilience to stress across the life span: A neurobiologic framework Fatih OzbayHeidi FitterlingSteven Southwick OriginalPaper 16 October 2008 Pages: 304 - 310
Advances in understanding illness anxiety Kelli J. HardingNatalia SkritskayaBrian A. Fallon OriginalPaper 16 October 2008 Pages: 311 - 317
Emerging treatments for Tourette’s disorder Michael H. Bloch OriginalPaper 16 October 2008 Pages: 323 - 330
Schizophrenia: From genes to phenes to disease Charlotte L. AllanAlastair G. CardnoPeter McGuffin OriginalPaper 16 October 2008 Pages: 339 - 343
Toward defining schizophrenia as a more useful clinical concept Jess G. FiedorowiczEric A. EppingMichael Flaum OriginalPaper 16 October 2008 Pages: 344 - 351
Better pharmacotherapy for schizophrenia: What does the future hold? Michael A. WebberStephen R. Marder OriginalPaper 16 October 2008 Pages: 352 - 358
Tactics and technologies to manage nonadherence in patients with schizophrenia William M. GlazerMathew J. Byerly OriginalPaper 16 October 2008 Pages: 359 - 369